According to TherapeuticsMD's latest financial reports and stock price the company's current number of shares outstanding is 10,701,000. At the end of 2023 the company had 10,701,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 10.7 M | 15.55% |
2022 | 9.26 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Pfizer PFE | 5,647,000,000 | 52,670.77% | ๐บ๐ธ USA |
AbbVie ABBV | 1,765,940,733 | 16,402.58% | ๐บ๐ธ USA |
Agile Therapeutics
AGRX | 2,950,136 | -72.43% | ๐บ๐ธ USA |
Royalty Pharma RPRX | 448,439,000 | 4,090.63% | ๐ฌ๐ง UK |
Lannett Company LCI | 10,311,428 | -3.64% | ๐บ๐ธ USA |